Xfund

Xfund Research Investment Thesis Xfund is the early-stage venture capital firm built to back entrepreneurs who think laterally and experiment across disciplines. The fund's distinctive thesis centers on identifying and supporting multidisciplinary thinkers—founders who can move fluidly across different domains and perspectives. Rather than purely technical expertise, Xfund values creative problem-solving, intellectual curiosity, and an ability to synthesize insights across fields. The firm is built on a belief that technical talent is necessary but not sufficient to build the world's most durable companies. Xfund seeks out entrepreneurs with multidisciplinary abilities who will become more insightful innovators. The fund explicitly welcomes founders from non-traditional backgrounds—whether they're students, faculty, staff, alumni, or entirely self-taught individuals—as long as they demonstrate a curious mind and an ability to execute. Fund Structure and Partnerships Xfund is a pioneering partnership between some of the country's most successful venture capital firms and some of the world's best research universities in the United States and abroad. The fund leverages relationships with leading universities including Harvard, MIT, and Stanford, providing portfolio companies with unparalleled access to academic talent, research, and institutional networks. Xfund was co-founded in 2014 and has evolved its leadership. The fund is currently co-managed by Patrick Chung and Brandon Farwell, two partners who have worked together for over a decade, alongside an extended investment and university team. Notable partners and advisors include Jim Breyer (Breyer Capital), who has been a long-time supporter and brings relationships with world-class universities. Stage Focus Xfund focuses on early-stage investments with a primary emphasis on seed-stage rounds. The fund invests across multiple rounds including: Seed stage: Primary focus Series A: Selective follow-on investments in existing portfolio companies Occasional pre-seed: For exceptional technical founders Fund Size and Check Size Xfund 3 closed with $120M in committed capital (September 2020), surpassing its initial $100M target. Typical seed investments range from $500K to $5M+, with follow-on investments reaching $5M to $40M+ in Series A and B rounds. Lead Tendency Xfund has a mixed lead/participate profile with many seed investments where Xfund is identified as lead investor, significant follow-on investments in Series A/B rounds alongside other leading VCs, and co-lead positions in larger rounds with top-tier partners. Recent Activity Recent investments include: December 17, 2025: BoldVoice Series A ($21M) December 9, 2025: BuildCheck AI Seed ($5.9M) November 10, 2025: AirOps Series B ($40M) May 28, 2025: Chalk Series A ($50M) Xfund has completed exits including Pomelo (acquired by Zepz, January 2026) and 8+ other portfolio exits. Fund III is actively deploying capital. Portfolio Highlights Xfund has made 75+ investments across diverse sectors including healthcare and biotech (23andMe, Curebase, Barinthusbio), enterprise software and developer tools (AirOps, Chalk, Forma AI), consumer applications (Zumper, Philo, Pomelo), and deep tech/robotics (AeroVect, Crabi Robotics). Team and Advisors Core leadership includes Patrick Chung (MGP), Brandon Farwell (Co-Manager), and Jadyn Bryden (VP). The fund benefits from distinguished faculty advisors including Harry Lewis, Debora Spar, Tom Eisenmann, and Bob Pozen from Harvard, demonstrating deep institutional integration with leading universities. Geographic and University Focus Headquarters in Cambridge with offices in Palo Alto. Deep partnerships with Harvard University, MIT, and Stanford, providing portfolio companies with unparalleled access to academic talent, research, and institutional networks. Key Differentiators University-Centric: Structurally integrated with university partnerships, particularly Harvard Lateral Thinking: Explicit focus on founders who think across disciplines Multidisciplinary Network: Faculty advisors and academic partnerships provide strategic advantage Early-Stage Specialization: Seed-focused with demonstrated follow-on capability Diverse Sector Coverage: Portfolio spans biotech, enterprise software, consumer, and deep tech Top-Tier Syndication: Regular partnerships with leading VCs (Felicis, Greylock, Unusual Ventures)